These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8336552

  • 21. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL, Wang AH, Wang CW, Cheng WT, Li SY, Lo HJ, TSARY Hospitals.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [Abstract] [Full Text] [Related]

  • 22. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, Fu W, Colombo AL, Rodriguez-Noriega E, Global Antifungal Surveillance Study.
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [Abstract] [Full Text] [Related]

  • 23. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
    Cheng MF, Yu KW, Tang RB, Fan YH, Yang YL, Hsieh KS, Ho M, Lo HJ.
    Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
    [Abstract] [Full Text] [Related]

  • 24. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years.
    Chen YC, Chang SC, Luh KT, Hsieh WC.
    J Antimicrob Chemother; 2003 Jul; 52(1):71-7. PubMed ID: 12775680
    [Abstract] [Full Text] [Related]

  • 25. Antifungal activity of black tea polyphenols (catechins and theaflavins) against Candida species.
    Sitheeque MA, Panagoda GJ, Yau J, Amarakoon AM, Udagama UR, Samaranayake LP.
    Chemotherapy; 2009 Jul; 55(3):189-96. PubMed ID: 19420933
    [Abstract] [Full Text] [Related]

  • 26. Candida species, genotypes and antifungal susceptibility of Candida isolates from blood samples of patients at the largest tertiary care hospital in Thailand during 1999-2002.
    Foongladda S, Sakulmaiwatana P, Petlum P, Vanprapar N.
    J Med Assoc Thai; 2004 Jan; 87(1):92-9. PubMed ID: 14971541
    [Abstract] [Full Text] [Related]

  • 27. Differentiation of Candida dubliniensis on chrom agar and Pal's agar.
    Raut SH, Varaiya A.
    Indian J Med Microbiol; 2009 Jan; 27(1):55-8. PubMed ID: 19172062
    [Abstract] [Full Text] [Related]

  • 28. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
    Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N.
    Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
    [Abstract] [Full Text] [Related]

  • 29. Molecular epidemiology of Candida species isolated from urine at an intensive care unit.
    Ergon MC, Gülay Z.
    Mycoses; 2005 Mar; 48(2):126-31. PubMed ID: 15743431
    [Abstract] [Full Text] [Related]

  • 30. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
    Quindós G, Sánchez-Vargas LO, Villar-Vidal M, Eraso E, Alkorta M, Hernández-Almaraz JL.
    Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
    [Abstract] [Full Text] [Related]

  • 31. [Evaluation of Candida species' susceptibility to fluconazole with the disk diffusion method].
    de Bedout C, Ayabaca J, Vega R, Méndez M, Santiago AR, Pabón ML, Tabares A, Arango M, Restrepo A, Newell V.
    Biomedica; 2003 Mar; 23(1):31-7. PubMed ID: 12696397
    [Abstract] [Full Text] [Related]

  • 32. Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001-2006.
    Metwally L, Walker MJ, Coyle PV, Hay RJ, Hedderwick S, McCloskey BV, O'Neill HJ, Webb CH, McMullan R.
    J Infect; 2007 Aug; 55(2):174-8. PubMed ID: 17560655
    [Abstract] [Full Text] [Related]

  • 33. Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro.
    Nikawa H, Samaranayake LP, Hamada T.
    Arch Oral Biol; 1995 Jun; 40(6):581-4. PubMed ID: 7677606
    [Abstract] [Full Text] [Related]

  • 34. Hyaluronidase and chondroitin sulphatase production by different species of Candida.
    Shimizu MT, Jorge AO, Unterkircher CS, Fantinato V, Paula CR.
    J Med Vet Mycol; 1995 Jun; 33(1):27-31. PubMed ID: 7650575
    [Abstract] [Full Text] [Related]

  • 35. Growth of pathogenic Candida isolates anaerobically and under elevated concentrations of CO2 in air.
    Webster CE, Odds FC.
    J Med Vet Mycol; 1987 Feb; 25(1):47-53. PubMed ID: 3106612
    [Abstract] [Full Text] [Related]

  • 36. [Detection of secretory acid proteinase enzyme from Candida strains on protein supplemented agar media].
    Cerikcioğlu N, Alaçam R.
    Mikrobiyol Bul; 1993 Oct; 27(4):344-51. PubMed ID: 8264448
    [Abstract] [Full Text] [Related]

  • 37. Respiration of medically important Candida species and Saccharomyces cerevisiae in relation to glucose effect.
    Niimi M, Kamiyama A, Tokunaga M.
    J Med Vet Mycol; 1988 Jun; 26(3):195-8. PubMed ID: 3050010
    [Abstract] [Full Text] [Related]

  • 38. [Effect of nystatin on Candida albicans in the proteolysis culture filtrate of Candida albicans].
    Staib F, Grühn G.
    Zentralbl Bakteriol Orig A; 1971 Nov; 218(3):369-73. PubMed ID: 4400274
    [No Abstract] [Full Text] [Related]

  • 39. In vitro susceptibility of Candida species to lactoferrin.
    Xu YY, Samaranayake YH, Samaranayake LP, Nikawa H.
    Med Mycol; 1999 Feb; 37(1):35-41. PubMed ID: 10200932
    [Abstract] [Full Text] [Related]

  • 40. The in vitro proteolytic and saccharolytic activity of Candida species cultured in human saliva.
    Samaranayake YH, MacFarlane TW, Samaranayake LP, Aitchison T.
    Oral Microbiol Immunol; 1994 Aug; 9(4):229-35. PubMed ID: 7478763
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.